Overexpression of TPL2 may be a predictor of good prognosis in patients with breast invasive ductal carcinoma
Abstract The objective of this study was to investigate the clinical significance and roles of tumor progression locus 2 (TPL2) and peptidyl-prolyl cis–trans isomerase 1 (Pin1) in the occurrence and development of breast invasive ductal carcinoma (IDC). Immunohistochemistry was used to detect the ex...
Main Authors: | Qin Yu, Dan Wan, Rong Fu, Feng Li, Yutao Zhang |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado: |
Nature Portfolio
2023-10-01
|
Series: | Scientific Reports |
Acceso en liña: | https://doi.org/10.1038/s41598-023-44660-z |
Títulos similares
-
Schirrous invasive ductal carcinoma of the breast overexpress p53 oncoprotein
por: Flávia Silva Ferrini, et al.
Publicado: (2001-01-01) -
The prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in the breast: a meta-analysis
por: Yun Wu, et al.
Publicado: (2017-12-01) -
UPAR Overexpression Could Be a Potential Favorable Prognostic Marker in Invasive Ductal Carcinoma of Breast
por: Ata Abbasi, et al.
Publicado: (2022-06-01) -
DCIS (Ductal carcinoma in situ)-like invasive ductal carcinoma of the breast
por: Huanyu Zhao, et al.
Publicado: (2022-10-01) -
Different distribution of breast ductal carcinoma <it>in situ</it>, ductal carcinoma <it>in situ</it> with microinvasion, and invasion breast cancer
por: Wei Zhang, et al.
Publicado: (2012-12-01)